Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The treatment of severe and active Crohn's disease is currently based on immunosuppression, but also involves the management of nutrition, appropriate selection of patients for surgery, and maintenance of remission in the long term. Corticosteroids remain the drug of the first choice, particularly in the acute setting. However, there is evolving understanding of the role of other immunosuppressants and immune modifiers, as major concerns regarding side-effects and efficacy of steroids in the medium to long-term drive the search for alternatives.

Type

Journal article

Journal

Aliment Pharmacol Ther

Publication Date

05/2001

Volume

15

Pages

563 - 573

Keywords

Acute Disease, Adrenal Cortex Hormones, Chronic Disease, Crohn Disease, Humans, Immunosuppressive Agents, Patient Care Planning, Prognosis, Severity of Illness Index